Allergan Wins First Approval for Short-Acting Neurotoxin in Canada
The product is the first botulinum toxin type E approved for aesthetic use and is designed to deliver faster onset and shorter-lasting results than traditional neurotoxins.
Latest News & Information
Staff's Top Picks
Why One Plastic Surgeon Believes Ultrasound-Guided BBLs Are the Future
As ultrasound-guided gluteal fat grafting gains momentum, plastic surgeons are debating whether the technology should become the standard for BBL procedures. In this interview, S. Alexander Earle, MD, FACS, discusses real-time visualization, surgeon adoption, Florida's ultrasound mandate, and why he believes the specialty is moving toward broader use of the technology.
Smarter Tools. Better Outcomes. One Weekly Update.
From cutting-edge procedures to patient experience strategies, we deliver the plastic surgery insights that help you save time, improve results, and grow your practice.Plastic Surgery Podcast
Clinic Excellence
Consumer Survey Reveals What Drives Aesthetic Treatment Decisions
Younger adult consumers say satisfaction with their appearance impacts their mental (62%) and physical (53%) well-being.
Future Focus Trends
Empowering Plastic Surgery Practices with Better Financing Technology for Operational Excellence and Access to Care
As patient demand for aesthetic procedures grows, financing technology is evolving to help plastic surgery practices improve access to care, streamline operations, and support patients navigating out-of-pocket treatment costs.
Products Shaping Aesthetics
Office Management Solutions
New Dashboard Tracks How Aesthetic Patients Combine Treatments and Products
Guidepoint Qsight's new analytics tool examines treatment pairings, repeat visits, and cross-purchasing trends across medical aesthetics.
